Friday, 30 June 2023

Subarachnoid Hemorrhage in Autoimmune Vasculitis: A Rare Study of SLE-Anca Vasculitis Overlap Syndrome | Chapter 4 | New Advances in Medicine and Medical Science Vol. 7

 This record of what happened wants to highlight the significance of taking SLE-AAV overlap into report in patients the one have symptoms that are similar to those in the case report and to underline the importance of making an early disease because a delayed disease can be fateful. Systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis (AAV) distinct from one another while having corresponding clinical traits. It is uncommon for SLE and AAV to co-occur as coinciding conditions, that makes disease challenging. Here, we present an unusual merger of hemorrhagic stroke, SLE, and AAV that has only ever happened documented once. Multiple beneficial autoantibodies complicated the disease, but a kidney biopsy disclosed the true cause and helped at the beginning of immunosuppressive cure. Standard early surgical measures to lower excessive intracranial pressure were unsuccessful for the patient, but she considerably improved afterwards starting immunosuppressive medication, professed a temporal links.

Author(s) Details:

Sujith K. Palleti,
Nephrology, Edward Hines Jr. Veterans Administration Hospital, Hines, USA and Nephrology, Loyola University Medical Center, Maywood, USA.

Hanna Larson,
Internal Medicine, Edward Hines Jr. Veterans Administration Hospital, Hines, USA and Internal Medicine, Loyola University Medical Center, Maywood, USA.

Sreekant Avula,
Endocrinology, University of Minnesota, Minneapolis, USA.

Maria M. Picken,
Nephrology, Edward Hines Jr. Veterans Administration Hospital, Hines, USA and Nephrology, Loyola University Medical Center, Maywood, USA.

Anuradha Wadhwa,
Nephrology, Edward Hines Jr. Veterans Administration Hospital, Hines, USA and Nephrology, Loyola University Medical Center, Maywood, USA.

Please see the link here: https://stm.bookpi.org/NAMMS-V7/article/view/11034

No comments:

Post a Comment